Loading…
Legislative Progress
Introduced
October 12, 2023
Latest Action
December 17, 2024
Primary Sponsor
Melanie A. StansburyDemocratic(NM)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
432d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2023 · fourth_quarter · Health Issues
Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Telehealth: sent recommendations to the Senate Finance Subcommittee on Healths hearing, Ensuring Medicare Beneficiary Access: A Path to Telehealth Permanency; joined sign-on letter to CMS about reporting a practitioners home address when offering telehealth services. Medicare payment: Submitted testimony to the House Energy and Commerce Health Subcommittee hearing about Medicare payment, Whats the Prognosis?: Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors; joined sign-on letter to Congress with Medicare budget neutrality recommendations; sent letter to the Senate Finance Committees Open Executive Session on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (S 3430); joined sign-on letter to congressional leadership to avert the scheduled cut to the Medicare conversion factor; sent letter of support for Preserving Seniors Access to Physicians Act of 2023 (HR 6683); joined sign-on letter to congressional leadership about extending the advanced alternative payment model incentive bonus; sent letter to congressional leadership with recommendations for Medicare payment reform for 2024. MIPS: Joined sign-on letter in support of the SURS Extension Act (HR 5935). Rural Healthcare: Responded to House Ways and Means RFI on improving healthcare in rural and underserved areas. No Surprises Act: submitted comments to HHS on proposed No Surprises Act rule on independent dispute resolution operations; submitted recommendations to House Ways and Means Hearing, Reduced Care for Patients: Fallout From Flawed Implementation of Surprise Medical Billing Protections. Discrimination on the Basis of Disability: Submitted comments to HHS in response to their proposed rule about discrimination on the basis of disability. Laboratory Developed Tests: submitted comments to the FDA in response to their rulemaking on laboratory developed tests (LDT); joined sign-on letter to extend the comment deadline for FDAs LDT rulemaking; joined sign-on letter to Congress to urge FDA to pause LDT rulemaking and work on legislation. Electronic Funds Transfer Fees: Supported the No Fees for EFTs Act (HR 6487). Prior Authorization: Included support for the reintroduction of the Improving Seniors Timely Access to Care Act in our legislative recommendations to congressional leadership for 2024.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE